Inositec is pioneering the development of life-saving small molecule drugs based on inositol phosphate, a natural facilitator of diverse cellular functions. Using its broadly applicable InosituneTM technology to adjust the chemical and physical properties of inositol phosphate (IP6) analogs, Inositec is developing a novel class of drugs currently focusing on high-unmet medical needs related to calcification disorders. The lead compound INS-3001 is a cardiovascular calcification inhibitor in development for aortic valve stenosis. Inositec was founded in December 2015 based on the award-winning research of Dr. Mattias Ivarsson, Prof. Jean-Christophe Leroux and Prof. Bastien Castagner at ETH Zurich, Switzerland. Inositec was acquired by Vifor Pharma in 2021.
View Top Employees from Inositec AG| Website | https://www.viforpharma.com |
| Revenue | $608000 |
| Employees | 3 (0 on RocketReach) |
| Founded | 2015 |
| Address | 1 Technoparkstrasse, Zürich, Zurich 8005, CH |
| Phone | +41 44 271 07 55 |
| Technologies |
JavaScript,
HTML,
PHP
+11 more
(view full list)
|
| Industry | Pharmaceutical Manufacturing, Business Services General, Biotechnology, Business Services, Science and Engineering, Medical, Health Care, Pharmaceutical |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 541714 Companies, NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 5417 Companies, NAICS Code 541 Companies |
Looking for a particular Inositec AG employee's phone or email?
Inositec AG Questions
The Inositec AG annual revenue was $608000 in 2024.
Inositec AG is based in Zürich, Zurich.
The NAICS codes for Inositec AG are [541714, 54171, 54, 5417, 541].
The SIC codes for Inositec AG are [873, 87].
Related Companies
